| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/15/2008 | CA2405265C Method of preventing or treating diabetes |
| 04/15/2008 | CA2401910C Hydrophilic molecular disperse solutions of carvedilol |
| 04/15/2008 | CA2398389C Method for inhibiting a tumor |
| 04/15/2008 | CA2381797C Composition comprising a tramadol material and an anticonvulsant drug |
| 04/15/2008 | CA2370201C Skin care compositions containing a combination of skin care actives |
| 04/15/2008 | CA2360246C Use of a cyclohexenone long-chain alcohol for treating neurodegenerative diseases |
| 04/15/2008 | CA2358466C 17.beta.-acyl-17.alpha.-propynyl-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 04/15/2008 | CA2328920C Novel derivatives of 3,3-diphenylpropylamines |
| 04/15/2008 | CA2280629C Carotenoid formulations, comprising a mixture of .beta.-carotene, lycopene and lutein |
| 04/15/2008 | CA2250433C Human dnase ii |
| 04/15/2008 | CA2213693C Amorphous piretanide, piretanide polymorphs, process for their preparation and their use |
| 04/15/2008 | CA2200754C Process of making dosage units by wet granulation |
| 04/15/2008 | CA2171614C Pharmaceutical composition containing sialic acid derivatives |
| 04/15/2008 | CA2170379C Photosensitizers |
| 04/15/2008 | CA2154424C 1-phenyl-3-dimethylaminopropane compounds having a pharmaceutical effect |
| 04/15/2008 | CA2105888C Use of a direct thrombin inhibitor in the production of a drug presenting a thrombolytic activity |
| 04/13/2008 | CA2606658A1 Compositions and methods for treating neurological disorders or damage |
| 04/12/2008 | WO2008146283A2 Palonosetron salts with preparation and purification thereof |
| 04/12/2008 | CA2603199A1 Shigella ipad protein and its use as a vaccine against shigella infection |
| 04/12/2008 | CA2563690A1 Pharmaceutical compositions comprising intra- and extra- granular fractions |
| 04/10/2008 | WO2008043087A2 Bicyclic nitrogen-containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors |
| 04/10/2008 | WO2008043072A2 Cd80 antagonists for treating neoplastic disorders |
| 04/10/2008 | WO2008043031A1 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression |
| 04/10/2008 | WO2008043024A2 Oral pharmaceutical formulation comprising a sulfonyl bicyclic modulator of ppar for the treatment of disease |
| 04/10/2008 | WO2008043019A1 8-substituted 2-(benzimidazolyl) purine derivatives for immunosuppression |
| 04/10/2008 | WO2008042973A2 Lipid containing formulations |
| 04/10/2008 | WO2008042970A2 Chitosan-coated calcium sulfate based medicament delivery system |
| 04/10/2008 | WO2008042968A2 Di-fluoro containing compounds as cysteine protease inhibitors |
| 04/10/2008 | WO2008042928A2 Oxadiazole and thiadiazole derivatives as mitotic kinesin inhibitors and methods of use thereof |
| 04/10/2008 | WO2008042926A1 Cyclic modulators of chemokine receptor activity |
| 04/10/2008 | WO2008042925A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 04/10/2008 | WO2008042898A2 Ketoconazole enantiomer in humans |
| 04/10/2008 | WO2008042896A2 Tetra-substituted ndga derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use |
| 04/10/2008 | WO2008042892A2 Fatty acid amide hydrolase inhibitors for energy metabolism disorders |
| 04/10/2008 | WO2008042891A2 Chitosan ophthalmic devices and methods |
| 04/10/2008 | WO2008042867A2 Modulators of multiple kinases |
| 04/10/2008 | WO2008042841A2 Docetaxel compositions |
| 04/10/2008 | WO2008042806A2 Stilbenedisulfonic acid derivatives as inhibitors of retroviral integrase |
| 04/10/2008 | WO2008042796A2 Methods for myocardial imaging in patients having a history of pulmonary disease |
| 04/10/2008 | WO2008042795A2 Histone acetyle transferase activators and histone deacetylase inhibitors in the treatment of alcoholism |
| 04/10/2008 | WO2008042735A1 Tetrahydroquinoline, indoline, and related aniline derivatives of heterocycle-fused benzodioxan methylamines |
| 04/10/2008 | WO2008042688A2 Phlorizin analogs as inhibitors of sodium glucose co-transporter 2 |
| 04/10/2008 | WO2008042639A1 Compounds and compositions as protein kinase inhibitors |
| 04/10/2008 | WO2008042619A2 Self-preserved aqueous pharmaceutical compositions |
| 04/10/2008 | WO2008042557A2 Formulation and method for a shampoo for animals |
| 04/10/2008 | WO2008042480A2 Epoxide inhibitors of cysteine proteases |
| 04/10/2008 | WO2008042454A1 Methods and ophthalmic devices used in the treatment of ocular allergies |
| 04/10/2008 | WO2008042400A2 The title is vague |
| 04/10/2008 | WO2008042399A2 Method for treatment of macular degeneration |
| 04/10/2008 | WO2008042388A1 Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 04/10/2008 | WO2008042362A1 Arylamino-arylpropanolamine derivatives and methods of their use |
| 04/10/2008 | WO2008042356A1 Carisoprodol, phenytoin and fosphenytoin articles and methods |
| 04/10/2008 | WO2008042353A1 Potent and highly selective heteroaromatic inhibitors of neuronal nitric oxide synthase |
| 04/10/2008 | WO2008042282A2 Imidazole-4, 5-dicarboxamide derivatives as jak-2 modulators |
| 04/10/2008 | WO2008042240A2 Enantiomerically pure phosphoindoles as hiv inhibitors |
| 04/10/2008 | WO2008042223A1 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 04/10/2008 | WO2008042222A2 Amide dendrimer compositions |
| 04/10/2008 | WO2008042146A1 Amine base salts of saha and polymorphs thereof |
| 04/10/2008 | WO2008042139A2 Azithromycin for the treatment of nodular acne |
| 04/10/2008 | WO2008042024A2 Neuroactive fragments of app |
| 04/10/2008 | WO2008041989A1 Method for the inhibition of plasmodium in a plasmodium-infected patient |
| 04/10/2008 | WO2008041914A1 5-(2-AMINO-L-HYDROXYETHYL)-8-HYDROXY-2-OXOQUINOLINE DERIVATIVES AND OTHER COMPOUNDS AS β2 -ADRENERGIC AGONISTS |
| 04/10/2008 | WO2008041882A1 Method for affecting viruses by means of an agent based on 2,8-ditioxo-1h-pyrano[2,3-d;6,5-d'] dipyrimidine and 10-aza-analogs thereof (variants) |
| 04/10/2008 | WO2008041843A1 Inhibition of cholera toxins by galatooligosaccharides (gos) |
| 04/10/2008 | WO2008041751A1 Pharmaceutical preparation for treating fibromyalgia |
| 04/10/2008 | WO2008041665A1 Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis c |
| 04/10/2008 | WO2008041663A1 Medicinal package |
| 04/10/2008 | WO2008041610A1 Compound of resorcinol derivative with polymer |
| 04/10/2008 | WO2008041553A1 Tacrolimus sustained-release preparation |
| 04/10/2008 | WO2008041525A1 Furylmethylene malonamide compound and salt thereof, ultraviolet ray absorbent, and external preparation for skin |
| 04/10/2008 | WO2008041514A1 Radiation sensitizer or anti-cancer chemotherapy sensitizer |
| 04/10/2008 | WO2008041460A1 Active oxygen scavenger, activating agent and collagen production promoter each comprising cacalol |
| 04/10/2008 | WO2008041264A1 Isoindolo-quinoxaline derivatives having antitumor activity, process for their production and their use |
| 04/10/2008 | WO2008041246A2 Injectable depot composition and its' process of preparation |
| 04/10/2008 | WO2008041236A2 Composition comprising crustacean gastrolith components, calcium carbonate and its use |
| 04/10/2008 | WO2008041131A2 Anticoagulant compounds |
| 04/10/2008 | WO2008041118A2 Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists |
| 04/10/2008 | WO2008041095A1 Sulfonamide derivatives as adrenergic agonists and muscarinic antagonists |
| 04/10/2008 | WO2008041090A1 Malanin concentrating hormone receptor-1 antagonist pyridinones |
| 04/10/2008 | WO2008041088A2 N-hydroxy benzamides with antitumor activity |
| 04/10/2008 | WO2008041087A1 An improved process for preparation of amorphous nelfinavir mesylate |
| 04/10/2008 | WO2008041075A1 Mglur5 modulators |
| 04/10/2008 | WO2008041037A1 Fused indoles and indazoles as inhibitors of poly(adp-ribose)polymerase (parp) |
| 04/10/2008 | WO2008041003A2 Hydroxycholesterols and its prodrugs for the treatment of insulin resistance and disorers asociated therewith |
| 04/10/2008 | WO2008040995A1 Indazoles for use as dpp-iv inhibitors |
| 04/10/2008 | WO2008040993A1 Pharmaceutical formulation of risedronate |
| 04/10/2008 | WO2008040974A1 Indoles for use as dpp-iv inhibitors |
| 04/10/2008 | WO2008040967A1 Treatment of fibrosis |
| 04/10/2008 | WO2008040951A1 Compounds |
| 04/10/2008 | WO2008040935A1 New polymorphic forms of pregabalin |
| 04/10/2008 | WO2008040934A1 Hdac inhibitors |
| 04/10/2008 | WO2008040816A1 Amorphous asenapine and processes for preparing same |
| 04/10/2008 | WO2008040799A2 Process for preparing instant forms of aqueous mixed micellar solutions as physiological buffer systems for use in the analysis of in vitro release |
| 04/10/2008 | WO2008040778A2 Carboxamide 4-[(4-pyridyl)amino] pyrimidines for the treatment of hepatitis c |
| 04/10/2008 | WO2008040774A2 Angiotensin ii receptor antagonist for the treatment of systemic diseases in cats |
| 04/10/2008 | WO2008040764A1 Substituted 4-phenyl piperidines for use as renin inhibitors |
| 04/10/2008 | WO2008040763A1 Pharmaceutical compositions comprising bisphosphonates |
| 04/10/2008 | WO2008040756A1 Anandamide |
| 04/10/2008 | WO2008040753A1 Indazolyl derivatives useful as potassium channel modulating agents |
| 04/10/2008 | WO2008040651A1 3-pyridinecarboxamide and 2-pyrazinecarboxamide derivatives as hdl-cholesterol raising agents |